Neural induction drives body axis formation during embryogenesis, but a neural induction-like process drives tumorigenesis in postnatal animals
暂无分享,去创建一个
[1] T. Kuner,et al. Glioblastoma hijacks neuronal mechanisms for brain invasion , 2022, Cell.
[2] P. Saw,et al. Targeting CAFs to overcome anticancer therapeutic resistance. , 2022, Trends in cancer.
[3] N. Normanno,et al. In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies , 2022, Journal for ImmunoTherapy of Cancer.
[4] J. Creemers,et al. The proprotein convertase furin in cancer: more than an oncogene , 2022, Oncogene.
[5] M. Zhang,et al. Neural stemness unifies cell tumorigenicity and pluripotent differentiation potential , 2021, bioRxiv.
[6] N. Callewaert,et al. T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy , 2021, Cancers.
[7] A. Yoshimi,et al. Aberrant RNA splicing and therapeutic opportunities in cancers , 2021, Cancer science.
[8] Xuehao Wang,et al. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges , 2021, Frontiers in Cell and Developmental Biology.
[9] A. Shilatifard,et al. Dietary palmitic acid promotes a prometastatic memory via Schwann cells , 2021, Nature.
[10] Ying Cao. Neural is Fundamental: Neural Stemness as the Ground State of Cell Tumorigenicity and Differentiation Potential , 2021, Stem Cell Reviews and Reports.
[11] Ying Cao,et al. Coordinated regulation of the ribosome and proteasome by PRMT1 in the maintenance of neural stemness in cancer cells and neural stem cells , 2021, The Journal of biological chemistry.
[12] J. de Magalhães. Every gene can (and possibly will) be associated with cancer. , 2021, Trends in genetics : TIG.
[13] Ying Cao,et al. Suppression of Cell Tumorigenicity by Non-neural Pro-differentiation Factors via Inhibition of Neural Property in Tumorigenic Cells , 2021, Frontiers in Cell and Developmental Biology.
[14] C. Galassi,et al. The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure , 2021, Cells.
[15] Z. Tian,et al. Rectal adenocarcinoma with multifocal osteoid differentiation. , 2021, Asian Journal of Surgery.
[16] S. Sadeghi,et al. Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them , 2021, International journal of molecular sciences.
[17] T. Brabletz,et al. Dynamic EMT: a multi‐tool for tumor progression , 2021, The EMBO journal.
[18] S. Wiemann,et al. Cancer-Associated Fibroblasts: Implications for Cancer Therapy , 2021, Cancers.
[19] T. Lee,et al. Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers , 2021, Frontiers in Cell and Developmental Biology.
[20] T. Sellers,et al. Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma , 2021, BMC cancer.
[21] Y. Buganim,et al. Targeting neurons in the tumor microenvironment with bupivacaine nanoparticles reduces breast cancer progression and metastases , 2021, bioRxiv.
[22] K. Bussey,et al. Cancer progression as a sequence of atavistic reversions , 2021, BioEssays : news and reviews in molecular, cellular and developmental biology.
[23] Yvonne Y. Chen,et al. Navigating CAR-T cells through the solid-tumour microenvironment , 2021, Nature Reviews Drug Discovery.
[24] Jacob D. Jaffe,et al. Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity , 2021, Nature.
[25] R. Weinberg,et al. Linking EMT programmes to normal and neoplastic epithelial stem cells , 2021, Nature Reviews Cancer.
[26] Rasheed Omobolaji Alabi,et al. Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis , 2021, BMC cancer.
[27] Rosalie M Sterner,et al. CAR-T cell therapy: current limitations and potential strategies , 2021, Blood Cancer Journal.
[28] M. Ferrer,et al. Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer , 2021, Oncogene.
[29] Robin L. Jones,et al. Extraskeletal osteosarcomas: current update. , 2021, Future oncology.
[30] S. Loi,et al. Intratumoral heterogeneity in cancer progression and response to immunotherapy , 2021, Nature Medicine.
[31] H. Pijl,et al. Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer , 2020, International journal of cancer.
[32] Ying Cao,et al. Neural stemness contributes to cell tumorigenicity , 2020, Cell & Bioscience.
[33] R. Sambasivan,et al. Neuromesodermal Progenitors: A Basis for Robust Axial Patterning in Development and Evolution , 2021, Frontiers in Cell and Developmental Biology.
[34] G. Calin,et al. Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk , 2020, Cancer Research.
[35] É. Vivier,et al. Tumor-Infiltrating Natural Killer Cells. , 2020, Cancer discovery.
[36] K. Lehti,et al. Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer , 2020, Frontiers in Oncology.
[37] Katherine Cosmopoulos,et al. Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition. , 2020, Trends in immunology.
[38] F. Marcucci,et al. The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer? , 2020, Cellular and Molecular Life Sciences.
[39] R. Drapkin,et al. Tumor Innervation: Cancer Has Some Nerve. , 2020, Trends in cancer.
[40] A. Rustgi,et al. EMT, MET, Plasticity, and Tumor Metastasis. , 2020, Trends in cell biology.
[41] E. Calvo,et al. Clinical Challenges of Immune Checkpoint Inhibitors. , 2020, Cancer cell.
[42] B. Stanger,et al. How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy , 2020, Cancer Research.
[43] Rodolfo Daniel Cervantes-Villagrana,et al. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies , 2020, Signal Transduction and Targeted Therapy.
[44] M. K. Siu,et al. Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression , 2020, Cancer Immunology, Immunotherapy.
[45] D. Tuveson,et al. DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS. , 2020, Physiological reviews.
[46] I. Aifantis,et al. RNA Splicing and Cancer. , 2020, Trends in cancer.
[47] Joshua M. Weiss,et al. Developmental chromatin programs determine oncogenic competence in melanoma , 2020, bioRxiv.
[48] Xi C. He,et al. Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells , 2020, Nature Cell Biology.
[49] Raymond B. Runyan,et al. Guidelines and definitions for research on epithelial–mesenchymal transition , 2020, Nature Reviews Molecular Cell Biology.
[50] M. Hellmann,et al. Acquired Resistance to Immune Checkpoint Inhibitors. , 2020, Cancer cell.
[51] G. Gao,et al. Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy , 2020, Proceedings of the National Academy of Sciences.
[52] D. Pe’er,et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance , 2020, Nature Reviews Clinical Oncology.
[53] K. Zilles,et al. Neurodevelopment , 2020, New Oxford Textbook of Psychiatry.
[54] Masahide Takahashi,et al. Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives , 2020, Cancer science.
[55] K. D. de Visser,et al. Immune crosstalk in cancer progression and metastatic spread: a complex conversation , 2020, Nature Reviews Immunology.
[56] T. Cai,et al. A Switch in Tissue Stem Cell Identity Causes Neuroendocrine Tumors in Drosophila Gut. , 2020, Cell reports.
[57] Jing Wang,et al. Loss of p53 drives neuron reprogramming in head and neck cancer , 2020, Nature.
[58] H. Putter,et al. The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer , 2020, International journal of cancer.
[59] I. Kozeretska,et al. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype , 2019, International journal of cancer.
[60] A. Dimberg,et al. Tumor angiogenesis: causes, consequences, challenges and opportunities , 2019, Cellular and Molecular Life Sciences.
[61] T. Tajiri,et al. Derivation of neural stem cells from human teratomas. , 2019, Stem cell research.
[62] A. Ribas,et al. Tumour-intrinsic resistance to immune checkpoint blockade , 2019, Nature Reviews Immunology.
[63] Xiaojing Ma,et al. Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti–PD-1 Resistance in Head and Neck Cancer , 2019, Clinical Cancer Research.
[64] Hsi-Wen Yeh,et al. A New Switch for TGFβ in Cancer. , 2019, Cancer research.
[65] James R. Anderson,et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study. , 2019, The Lancet. Oncology.
[66] L. Shevde,et al. The Tumor Microenvironment Innately Modulates Cancer Progression. , 2019, Cancer research.
[67] E. D. De Robertis,et al. Transcriptome analysis of regeneration during Xenopus laevis experimental twinning. , 2019, The International journal of developmental biology.
[68] M. Merad,et al. β-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. , 2019, Cancer discovery.
[69] E. Fuchs,et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells , 2019, Cell.
[70] Ying Cao,et al. EZH2 Regulates Protein Stability via Recruiting USP7 to Mediate Neuronal Gene Expression in Cancer Cells , 2019, Front. Genet..
[71] Y. Allory,et al. Progenitors from the central nervous system drive neurogenesis in cancer , 2019, Nature.
[72] H. Lamb,et al. Primary Osteosarcoma of the Breast. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.
[73] Hiromasa Morikawa,et al. PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer , 2019, Proceedings of the National Academy of Sciences.
[74] B. Stanger,et al. Cellular Plasticity in Cancer. , 2019, Cancer discovery.
[75] Michael Bordonaro,et al. Quantum biology and human carcinogenesis , 2019, Biosyst..
[76] R. Tollenaar,et al. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer , 2019, BMC cancer.
[77] Masahide Takahashi,et al. Cancer-associated fibroblasts in gastrointestinal cancer , 2019, Nature Reviews Gastroenterology & Hepatology.
[78] G. Christofori,et al. Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis. , 2019, Cancer cell.
[79] Morris Laster,et al. When cancer meets quantum mechanics. , 2019, Theoretical biology forum.
[80] Georgios Giamas,et al. Astrocytes, the rising stars of the glioblastoma microenvironment , 2018, Glia.
[81] J. Doench,et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade , 2018, Nature.
[82] M. Smyth,et al. Cancer immunoediting and resistance to T cell-based immunotherapy , 2018, Nature Reviews Clinical Oncology.
[83] P. Muñoz,et al. Cancer cell plasticity: Impact on tumor progression and therapy response. , 2018, Seminars in cancer biology.
[84] A. Monsoro-Burq,et al. The neural border: Induction, specification and maturation of the territory that generates neural crest cells. , 2018, Developmental biology.
[85] A. Monsoro-Burq,et al. AKT signaling displays multifaceted functions in neural crest development. , 2018, Developmental biology.
[86] J. Soria,et al. Hyperprogressive disease: recognizing a novel pattern to improve patient management , 2018, Nature Reviews Clinical Oncology.
[87] M. Donia,et al. Acquired resistance to cancer immunotherapy , 2018, Seminars in Immunopathology.
[88] U. Chatterji,et al. Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT , 2018, Journal of cellular biochemistry.
[89] B. Sáinz,et al. Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts. , 2018, Critical reviews in oncology/hematology.
[90] Shelly Maman,et al. A history of exploring cancer in context , 2018, Nature Reviews Cancer.
[91] A. Martinez Arias,et al. On the nature and function of organizers , 2018, Development.
[92] J. Wargo,et al. The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression , 2018, Clinical Cancer Research.
[93] V. Apostolopoulos,et al. Crosstalk between cancer and the neuro-immune system , 2018, Journal of Neuroimmunology.
[94] N. Bhardwaj,et al. Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment. , 2018, Trends in cancer.
[95] A. Dicker,et al. Blockade of Tumor-Expressed PD-1 promotes lung cancer growth , 2017, Oncoimmunology.
[96] H. Thé. Differentiation therapy revisited , 2018, Nature Reviews Cancer.
[97] C. Wright,et al. Prevention and reversion of pancreatic tumorigenesis through a differentiation-based mechanism , 2017, bioRxiv.
[98] J. Wilmott,et al. Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma , 2017, Clinical Cancer Research.
[99] Ying Cao. Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells , 2017, Cell & Bioscience.
[100] H. Okano,et al. Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells , 2017, Scientific Reports.
[101] C. Lindskog,et al. A pathology atlas of the human cancer transcriptome , 2017, Science.
[102] M. Zhang,et al. Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells , 2017, The Journal of Biological Chemistry.
[103] F. Baralle,et al. Alternative splicing as a regulator of development and tissue identity , 2017, Nature Reviews Molecular Cell Biology.
[104] Ruth Nussinov,et al. A New View of Pathway-Driven Drug Resistance in Tumor Proliferation. , 2017, Trends in pharmacological sciences.
[105] G. Kollias,et al. Mesenchymal Cells in Colon Cancer. , 2017, Gastroenterology.
[106] H. Hondermarck,et al. Nerve Dependence: From Regeneration to Cancer. , 2017, Cancer cell.
[107] H. Okano,et al. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro. , 2017, Stem cell research.
[108] J. Wargo,et al. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.
[109] H. Tomita,et al. Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling. , 2017, Cancer cell.
[110] Yanna Shang,et al. Neurons generated from carcinoma stem cells support cancer progression , 2017, Signal Transduction and Targeted Therapy.
[111] Araxi O. Urrutia,et al. Alternative splicing and the evolution of phenotypic novelty , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[112] C. Welter,et al. Origin of Cancer: An Information, Energy, and Matter Disease , 2016, Front. Cell Dev. Biol..
[113] Austin E. Gillen,et al. Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen , 2016, Clinical Cancer Research.
[114] J. Hartman,et al. Pericyte–fibroblast transition promotes tumor growth and metastasis , 2016, Proceedings of the National Academy of Sciences.
[115] Omar Abdel-Wahab,et al. Therapeutic targeting of splicing in cancer , 2016, Nature Medicine.
[116] A. Dutt,et al. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes , 2016, Modern Pathology.
[117] R. Weichselbaum,et al. Tumor-associated fibroblasts predominantly come from local and not circulating precursors , 2016, Proceedings of the National Academy of Sciences.
[118] X. de la Cruz,et al. EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing p21 , 2016, Open Biology.
[119] Aleksandr B. Sahakyan,et al. Long genes and genes with multiple splice variants are enriched in pathways linked to cancer and other multigenic diseases , 2016, BMC Genomics.
[120] Craig S. Wong,et al. Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[121] Claire Anderson,et al. Organizers in Development. , 2016, Current topics in developmental biology.
[122] D. Henrique,et al. Neuromesodermal progenitors and the making of the spinal cord , 2015, Development.
[123] Xiongfong Chen,et al. The Proto-oncogene Transcription Factor Ets1 Regulates Neural Crest Development through Histone Deacetylase 1 to Mediate Output of Bone Morphogenetic Protein Signaling* , 2015, The Journal of Biological Chemistry.
[124] AnjaliL . Rao,et al. Shared regulatory programs suggest retention of blastula-stage potential in neural crest cells , 2015, Science.
[125] B. Thisse,et al. Formation of the vertebrate embryo: Moving beyond the Spemann organizer. , 2015, Seminars in cell & developmental biology.
[126] T. Gajewski,et al. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity , 2015, Nature.
[127] H. Hondermarck,et al. Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression. , 2015, Cancer research.
[128] N. McGranahan,et al. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.
[129] R. Paduch. Theories of cancer origin , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[130] C. Théry,et al. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.
[131] N. Socci,et al. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations , 2014, Nature Genetics.
[132] Tony D. Southall,et al. Dedifferentiation of Neurons Precedes Tumor Formation in lola Mutants , 2014, Developmental cell.
[133] R. Weinberg. Coming Full Circle—From Endless Complexity to Simplicity and Back Again , 2014, Cell.
[134] G. Blin,et al. Bone morphogenic protein signalling suppresses differentiation of pluripotent cells by maintaining expression of E-Cadherin , 2013, eLife.
[135] C. Blanpain,et al. Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.
[136] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[137] Corbin E. Meacham,et al. Tumour heterogeneity and cancer cell plasticity , 2013, Nature.
[138] S. Freedland,et al. Autonomic Nerve Development Contributes to Prostate Cancer Progression , 2013, Science.
[139] D. Nam,et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. , 2013, Cancer cell.
[140] R. McLendon,et al. Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth , 2013, Cell.
[141] D. Munn,et al. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. , 2013, Trends in immunology.
[142] B F Warren,et al. The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[143] N. Harrison,et al. Rediscovering pluripotency: from teratocarcinomas to embryonic stem cells. Cardiff, 10-12 October 2011. , 2012, The International journal of developmental biology.
[144] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[145] H. Ulrich,et al. Neural differentiation of P19 carcinoma cells and primary neurospheres: cell morphology, proliferation, viability, and functionality. , 2012, Current protocols in stem cell biology.
[146] T. Misteli,et al. In vitro generation of human cells with cancer stem cell properties , 2011, Nature Cell Biology.
[147] A. Rangarajan,et al. Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters , 2011, Cell Death and Disease.
[148] Steven I Hajdu,et al. A note from history: Landmarks in history of cancer, part 2 , 2011, Cancer.
[149] C. Sonnenschein,et al. The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.
[150] Hans Clevers,et al. The cancer stem cell: premises, promises and challenges , 2011, Nature Medicine.
[151] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[152] Hiroyuki Tomita,et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.
[153] F. Sher,et al. Ezh2 expression in astrocytes induces their dedifferentiation toward neural stem cells. , 2011, Cellular reprogramming.
[154] Mauro Biffoni,et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.
[155] Rong Wang,et al. Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.
[156] V. Saradhi,et al. Teratomas in central nervous system: a clinico-morphological study with review of literature. , 2010, Neurology India.
[157] Jing Wang,et al. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo , 2010, Cancer biology & therapy.
[158] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[159] T. Keck,et al. ZEB1 in Pancreatic Cancer , 2010, Cancers.
[160] P. Collodi,et al. Zebrafish dead end possesses ATPase activity that is required for primordial germ cell development , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[161] N. Ferrara,et al. Targeting the tumour vasculature: insights from physiological angiogenesis , 2010, Nature Reviews Cancer.
[162] Sven Christian,et al. Origin and function of tumor stroma fibroblasts. , 2010, Seminars in cell & developmental biology.
[163] K. Takeshita,et al. Carcinosarcoma of the liver. , 2010, Internal medicine.
[164] Miguel C. Seabra,et al. Rab27a and Rab27b control different steps of the exosome secretion pathway , 2010, Nature Cell Biology.
[165] E. D. De Robertis,et al. Spemann’s organizer and the self-regulation of embryonic fields , 2009, Mechanisms of Development.
[166] A. Ghanate,et al. Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells , 2009, Stem cells.
[167] C. Mullighan,et al. Human Gastrointestinal Neoplasia‐Associated Myofibroblasts Can Develop from Bone Marrow‐Derived Cells Following Allogeneic Stem Cell Transplantation , 2009, Stem cells.
[168] R. Harland. Induction into the Hall of Fame: tracing the lineage of Spemann's organizer , 2008, Development.
[169] M. Todaro,et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.
[170] M. Singhal,et al. Primary mediastinal giant teratocarcinoma. , 2008, Indian journal of cancer.
[171] Mary J. C. Hendrix,et al. Reprogramming metastatic tumour cells with embryonic microenvironments , 2007, Nature Reviews Cancer.
[172] J. Odorico,et al. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. , 2006, Stem cells and development.
[173] A. Fritz,et al. Zebrafish msxB, msxC and msxE function together to refine the neural-nonneural border and regulate cranial placodes and neural crest development. , 2006, Developmental biology.
[174] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[175] D. Solter,et al. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research , 2006, Nature Reviews Genetics.
[176] E. D. Robertis,et al. Spemann's organizer and self-regulation in amphibian embryos , 2006, Nature Reviews Molecular Cell Biology.
[177] T. Curran,et al. BGEM: An In Situ Hybridization Database of Gene Expression in the Embryonic and Adult Mouse Nervous System , 2006, PLoS biology.
[178] M. Hendrix,et al. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[179] N. Benvenisty,et al. Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells , 2006, Stem cells.
[180] Chenbei Chang,et al. Regulation of early Xenopus development by ErbB signaling , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[181] D. van der Kooy,et al. Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences , 2006, The Journal of cell biology.
[182] J. Nadeau,et al. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours , 2005, Nature.
[183] E. D. De Robertis,et al. Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. , 2005, Genes & development.
[184] H. Spemann,et al. über Induktion von Embryonalanlagen durch Implantation artfremder Organisatoren , 1924, Archiv für mikroskopische Anatomie und Entwicklungsmechanik.
[185] Stuart R Hameroff,et al. A new theory of the origin of cancer: quantum coherent entanglement, centrioles, mitosis, and differentiation. , 2004, Bio Systems.
[186] E. D. De Robertis,et al. Dorsal-ventral patterning and neural induction in Xenopus embryos. , 2004, Annual review of cell and developmental biology.
[187] Rudolf Jaenisch,et al. Reprogramming of a melanoma genome by nuclear transplantation. , 2004, Genes & development.
[188] P. Johnstone,et al. Primary retroperitoneal teratomas: A review of the literature , 2004, Journal of surgical oncology.
[189] K. K. Chao,et al. Sinonasal teratocarcinosarcoma. , 2004, American journal of clinical oncology.
[190] J. Nichols,et al. BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3 , 2003, Cell.
[191] C. Uyttenhove,et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase , 2003, Nature Medicine.
[192] T. Curran,et al. Mouse embryos cloned from brain tumors. , 2003, Cancer research.
[193] Z. Kozmík,et al. Gelsolin is a dorsalizing factor in zebrafish , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[194] Austin G Smith,et al. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture , 2003, Nature Biotechnology.
[195] J. Brickman,et al. Pluripotency and tumorigenicity , 2002, Nature Genetics.
[196] A. Knecht,et al. Induction of the neural crest: a multigene process , 2002, Nature Reviews Genetics.
[197] P. Andrews,et al. From teratocarcinomas to embryonic stem cells. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[198] Ali H. Brivanlou,et al. Neural induction, the default model and embryonic stem cells , 2002, Nature Reviews Neuroscience.
[199] R. Harland,et al. The neural plate specifies somite size in the Xenopus laevis gastrula. , 2001, Developmental cell.
[200] Janet Rossant,et al. Direct Neural Fate Specification from Embryonic Stem Cells A Primitive Mammalian Neural Stem Cell Stage Acquired through a Default Mechanism , 2001, Neuron.
[201] A. Otte,et al. The Polycomb Group Protein EED Interacts with YY1, and Both Proteins Induce Neural Tissue in XenopusEmbryos , 2001, Molecular and Cellular Biology.
[202] J. Gerhart,et al. Evolution of the organizer and the chordate body plan. , 2001, The International journal of developmental biology.
[203] H. Spemann,et al. Induction of Embryonic Primordia by Implantation of Organizers from a Different Species. , 2024, Cells & development.
[204] U. Lendahl,et al. Generalized potential of adult neural stem cells. , 2000, Science.
[205] S. Gilbert. Neural crest cells and axonal specificity , 2000 .
[206] R. Harland. Neural induction. , 2000, Current opinion in genetics & development.
[207] Yang Shi,et al. Targeted Disruption of Mouse Yin Yang 1 Transcription Factor Results in Peri-Implantation Lethality , 1999, Molecular and Cellular Biology.
[208] M. Levin. Twinning and embryonic left-right asymmetry. , 1999, Laterality.
[209] D. Riethmacher,et al. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. , 1998, Genes & development.
[210] D. Gottlieb,et al. Neural cells derived by in vitro differentiation of P19 and embryonic stem cells. , 1998, Perspectives on developmental neurobiology.
[211] J. Sleeman,et al. Autonomous neural axis formation by ectopic expression of the protooncogene c-ski. , 1997, Developmental biology.
[212] J. J. Hoorweg,et al. Osteoid and bone formation in a nasal mucosal melanoma and its metastasis , 1997, Histopathology.
[213] C. Colmenares,et al. Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. , 1997, Genes & development.
[214] A. Hemmati‐Brivanlou,et al. Neural induction in Xenopus laevis: evidence for the default model , 1997, Current Opinion in Neurobiology.
[215] T. Bouwmeester,et al. Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer , 1996, Nature.
[216] D. Saranath,et al. A neural precursor cell line derived from murine teratocarcinoma. , 1996, The International journal of developmental biology.
[217] M J Bissell,et al. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.
[218] Rüdiger Klein,et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.
[219] K. Herrup,et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.
[220] M. Bronner‐Fraser,et al. Origins of the avian neural crest: the role of neural plate-epidermal interactions. , 1995, Development.
[221] T. Magnuson,et al. The eed mutation disrupts anterior mesoderm production in mice. , 1995, Development.
[222] Y. Sasai,et al. Xenopus chordin: A novel dorsalizing factor activated by organizer-specific homeobox genes , 1994, Cell.
[223] D. Melton,et al. Inhibition of activin receptor signaling promotes neuralization in Xenopus , 1994, Cell.
[224] Virginia M. Y. Lee,et al. NTera 2 Cells: A human cell line which displays characteristics expected of a human committed neuronal progenitor cell , 1993, Journal of neuroscience research.
[225] K. Kinzler,et al. The multistep nature of cancer. , 1993, Trends in genetics : TIG.
[226] William C. Smith,et al. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos , 1992, Cell.
[227] L. Tacke,et al. Neural differentiation of Xenopus laevis ectoderm takes place after disaggregation and delayed reaggregation without inducer. , 1989, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[228] J. Slack,et al. Clonal analysis of mesoderm induction in Xenopus laevis. , 1989, Developmental biology.
[229] T. Sargent,et al. Development of neural inducing capacity in dissociated Xenopus embryos. , 1989, Developmental biology.
[230] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[231] S D Carson,et al. Regulation of melanoma by the embryonic skin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[232] R. S. Wells,et al. Widespread inhibition of neuroblastoma cells in the 13- to 17-day-old mouse embryo. , 1986, Cancer research.
[233] H. Rubin. Cancer as a dynamic developmental disorder. , 1985, Cancer research.
[234] M. Moore,et al. Human tumor-infiltrating lymphocytes: a marker of host response. , 1985, Seminars in hematology.
[235] G. B. Pierce,et al. The neurula stage mouse embryo in control of neuroblastoma. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[236] L. Sachs,et al. Developmental potential of myeloid leukemia cells injected into midgestation embryos. , 1984, Developmental biology.
[237] S. Kottaridis,et al. Uncontrolled growth of tumour stromal fibroblasts in vitro. , 1983, Experimental cell biology.
[238] M. Mizell,et al. Frog larvae cloned from nuclei of pronephric adenocarcinoma. , 1982, Differentiation; research in biological diversity.
[239] G. B. Pierce. The cancer cell and its control by the embryo. Rous-Whipple Award lecture. , 1983, The American journal of pathology.
[240] L. Sachs,et al. Participation of myeloid leukaemic cells injected into embryos in haematopoietic differentiation in adult mice , 1982, Nature.
[241] H. Macdonald,et al. Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors , 1981, The Journal of experimental medicine.
[242] S. Argov,et al. Natural cytotoxicity in man: activity of lymph node and tumor‐infiltrating lymphocytes , 1977, European journal of immunology.
[243] H. Pinkus,et al. Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. , 1977, Cancer research.
[244] K. Illmensee,et al. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[245] M. Evans,et al. Fate of teratocarcinoma cells injected into early mouse embryos , 1975, Nature.
[246] R. Brinster. THE EFFECT OF CELLS TRANSFERRED INTO THE MOUSE BLASTOCYST ON SUBSEQUENT DEVELOPMENT , 1974, The Journal of experimental medicine.
[247] G. B. Pierce,et al. Differentiation of malignant to benign cells. , 1971, Cancer research.
[248] R. McKinnell,et al. Transplantation of Pluripotential Nuclei from Triploid Frog Tumors , 1969, Science.
[249] T. J. King,et al. TRANSPLANTATION OF NUCLEI FROM THE FROG RENAL ADENOCARCINOMA I. DEVELOPMENT OF TUMOR NUCLEAR‐TRANSPLANT EMBRYOS * , 1965, Annals of the New York Academy of Sciences.
[250] R. R. Bensley,et al. Embryonic Development and Induction , 1938, The Yale Journal of Biology and Medicine.